Proteome Sciences (LON:PRM) Shares Down 0.6% – Here’s Why

Proteome Sciences plc (LON:PRM)’s stock price fell 0.6% during trading on Monday . The stock traded as low as GBX 1.50 and last traded at GBX 1.70. 657,337 shares traded hands during trading, an increase of 54% from the average session volume of 425,694 shares. The stock had previously closed at GBX 1.71.

Proteome Sciences Trading Up 2.0%

The stock has a market capitalization of £5.26 million, a price-to-earnings ratio of -1.44 and a beta of 0.07. The company’s 50 day moving average is GBX 1.57 and its 200 day moving average is GBX 1.95. The company has a debt-to-equity ratio of -165.46, a quick ratio of 0.37 and a current ratio of 0.13.

Proteome Sciences (LON:PRM) last announced its quarterly earnings data on Wednesday, April 15th. The company reported GBX (1.04) earnings per share (EPS) for the quarter. The business had revenue of GBX 376 million during the quarter. Proteome Sciences had a negative net margin of 81.50% and a positive return on equity of 33.80%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.